KIT and gastrointestinal stromal tumor: In our previous study, we showed that this GIST patient (#25 in [30]) developed increasing fragment numbers and MAF for a cKIT exon 11 deletion, preceding radiological progression after nine months of regorafenib treatment (Figure 4D, lower panel, white arrow and Supplementary Materials Table S3).